Category: MS Research Study and Reports

COVID-19 May Not Be Severe in MS Patients, Early Data from Italy Suggest

 MAY 12, 2020  – BY MARTA FIGUEIREDO People with multiple sclerosis (MS) may not be at higher risk of developing a severe COVID-19 infection,…

Stuart Schlossman

New Study Links Obesity to Faster Nerve Loss in People with MS

Click HERE to Subscribe for the MS Beacon Newsletter April 23, 2020 Johns Hopkins University researchers funded in part by…

Stuart Schlossman

A Phase 2 Multicenter Study of Ublituximab, a Novel Glycoengineered anti-CD20 Monoclonal Antibody, in Patients With Relapsing Forms of Multiple Sclerosis

Click HERE to Subscribe for the MS Beacon Newsletter 2020  —  Background: Ublituximab, a novel monoclonal antibody (mAb) targeting a…

Stuart Schlossman

Ofatumumab (anti-CD20) Displays Superiority to Teriflunomide in Relapsing MS

Ofatumumab, Novartis’s fully human anti-CD20 monoclonal antibody, demonstrated a reduction in the risk of 3- and 6-month confirmed disability progression…

Stuart Schlossman

What Is COVID-19 Doing to the Brain?

Evidence is emerging that the virus that causes COVID-19 can invade the central nervous system.  By Trevis Gleason For Life With…

Stuart Schlossman

New 6-Year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in Relapsing Multiple Sclerosis

Post-hoc analysis from 6 years of Phase III open-label extension studies showed Ocrevus treatment reduced the risk of needing a…

Stuart Schlossman

Sanofi brain-penetrant BTK inhibitor significantly reduced disease activity in Phase 2 trial in relapsing multiple sclerosis

PRESS RELEASES    April 23 2020 Click HERE to Subscribe for the MS Beacon Newsletter Sanofi brain-penetrant BTK inhibitor significantly…

Stuart Schlossman

Coronavirus and MS Reporting Database

COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the National MS Society, Consortium of MS Centers and Multiple Sclerosis…

Stuart Schlossman

Monocytes May Be Better, Safer Targets for MS Therapies, Study Suggests

 APRIL 23, 2020  BY INES MARTINS, PHD Click HERE to Subscribe for the MS Beacon Newsletter A subset of monocytes (a type of immune…

Stuart Schlossman

Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course.

Rosalind Kalb 1, Theodore R Brown 2, Susan Coote 3, Kathleen Costello 1, Ulrik Dalgas 4, Eric Garmon 1, Barbara Giesser 5, June Halper 6, Herb Karpatkin 7, Jennifer Keller 8, Alexander V Ng 9, Lara A Pilutti 10, Amanda Rohrig 11, Paul Van Asch 12, Kathleen Zackowski 1, Robert…

Stuart Schlossman

Categories

Latest Blog Posts